SG54177A1 - Process for purification of a 69000 dalton antigenic protein from bordetella pertussis - Google Patents
Process for purification of a 69000 dalton antigenic protein from bordetella pertussisInfo
- Publication number
- SG54177A1 SG54177A1 SG1996003196A SG1996003196A SG54177A1 SG 54177 A1 SG54177 A1 SG 54177A1 SG 1996003196 A SG1996003196 A SG 1996003196A SG 1996003196 A SG1996003196 A SG 1996003196A SG 54177 A1 SG54177 A1 SG 54177A1
- Authority
- SG
- Singapore
- Prior art keywords
- bordetella pertussis
- purification
- dalton
- antigenic protein
- protein
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 241000588832 Bordetella pertussis Species 0.000 title abstract 3
- 238000000746 purification Methods 0.000 title abstract 2
- 230000000890 antigenic effect Effects 0.000 title 1
- 239000000022 bacteriostatic agent Substances 0.000 abstract 1
- 238000011098 chromatofocusing Methods 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000003252 repetitive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/448,777 US5276142A (en) | 1989-12-11 | 1989-12-11 | Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis |
Publications (1)
Publication Number | Publication Date |
---|---|
SG54177A1 true SG54177A1 (en) | 1998-11-16 |
Family
ID=23781640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1996003196A SG54177A1 (en) | 1989-12-11 | 1990-10-29 | Process for purification of a 69000 dalton antigenic protein from bordetella pertussis |
Country Status (13)
Country | Link |
---|---|
US (1) | US5276142A (de) |
EP (1) | EP0437687B1 (de) |
JP (1) | JP2950970B2 (de) |
KR (1) | KR0180527B1 (de) |
AT (1) | ATE137976T1 (de) |
AU (1) | AU641711B2 (de) |
CA (1) | CA2031763A1 (de) |
DE (1) | DE69027013T2 (de) |
DK (1) | DK0437687T3 (de) |
ES (1) | ES2087109T3 (de) |
FI (1) | FI101380B1 (de) |
NO (1) | NO301717B1 (de) |
SG (1) | SG54177A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
GB8910570D0 (en) * | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
US6197548B1 (en) | 1990-04-02 | 2001-03-06 | Medeva Pharma Limited | Transformed Pichia expressing the pertactin antigen |
GB9007657D0 (en) * | 1990-04-04 | 1990-05-30 | Connaught Lab | Purification of a pertussis outer membrane protein(omp69) |
EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
US6444211B2 (en) | 1991-04-03 | 2002-09-03 | Connaught Laboratories, Inc. | Purification of a pertussis outer membrane protein |
GB9304399D0 (en) * | 1993-03-04 | 1993-04-21 | Smithkline Beecham Biolog | Novel process |
CA2188424A1 (en) * | 1994-04-28 | 1995-11-09 | Akihiro Suehara | Method of separating protective components of bordetella pertussis |
DE19512346C1 (de) * | 1995-04-01 | 1996-06-13 | Behringwerke Ag | Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin |
NZ306392A (en) | 1995-05-04 | 1999-04-29 | Connaught Lab | Acellular pertussisvaccines, fimbrial agglutinogin preparation prepared from bordetella strain preparation |
US5877298A (en) * | 1995-05-04 | 1999-03-02 | Connaught Lab | Acellular pertussis vaccines and methods of preparing thereof |
GB9611501D0 (en) * | 1996-06-03 | 1996-08-07 | Smithkline Beecham Biolog | Vaccine compositions |
SK283565B6 (sk) | 1996-07-02 | 2003-09-11 | Connaught Laboratories Limited | Multivalentná imunogénna kompozícia a jej použitie |
WO2010131111A1 (en) * | 2009-05-11 | 2010-11-18 | Novartis Ag | Antigen purification process for pertactin antigen |
CN102584958A (zh) * | 2012-02-08 | 2012-07-18 | 北京天坛生物制品股份有限公司 | 百日咳杆菌69kd外膜蛋白的纯化方法 |
SG11201506858SA (en) | 2013-03-08 | 2015-09-29 | Crucell Holland Bv | Acellular pertussis vaccine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4220717A (en) * | 1977-12-22 | 1980-09-02 | American Cyanamid Company | Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b. |
GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
GB8512972D0 (en) * | 1985-05-22 | 1985-06-26 | Univ Glasgow | Vaccine production |
DK175308B1 (da) * | 1987-09-28 | 2004-08-16 | Pfizer | En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf |
US5101014A (en) * | 1989-02-10 | 1992-03-31 | United States Of America | Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis |
-
1989
- 1989-12-11 US US07/448,777 patent/US5276142A/en not_active Expired - Fee Related
-
1990
- 1990-10-29 AT AT90120662T patent/ATE137976T1/de not_active IP Right Cessation
- 1990-10-29 EP EP90120662A patent/EP0437687B1/de not_active Expired - Lifetime
- 1990-10-29 DK DK90120662.3T patent/DK0437687T3/da active
- 1990-10-29 ES ES90120662T patent/ES2087109T3/es not_active Expired - Lifetime
- 1990-10-29 SG SG1996003196A patent/SG54177A1/en unknown
- 1990-10-29 DE DE69027013T patent/DE69027013T2/de not_active Expired - Fee Related
- 1990-11-17 KR KR1019900018657A patent/KR0180527B1/ko not_active IP Right Cessation
- 1990-11-29 JP JP2326096A patent/JP2950970B2/ja not_active Expired - Lifetime
- 1990-12-07 CA CA002031763A patent/CA2031763A1/en not_active Abandoned
- 1990-12-10 AU AU67933/90A patent/AU641711B2/en not_active Ceased
- 1990-12-10 NO NO905324A patent/NO301717B1/no not_active IP Right Cessation
- 1990-12-10 FI FI906071A patent/FI101380B1/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI906071A0 (fi) | 1990-12-10 |
DE69027013T2 (de) | 1996-12-19 |
FI101380B (fi) | 1998-06-15 |
AU641711B2 (en) | 1993-09-30 |
AU6793390A (en) | 1991-06-13 |
EP0437687A2 (de) | 1991-07-24 |
KR910012234A (ko) | 1991-08-07 |
DE69027013D1 (de) | 1996-06-20 |
FI906071A (fi) | 1991-06-12 |
CA2031763A1 (en) | 1991-06-12 |
DK0437687T3 (da) | 1996-06-03 |
EP0437687A3 (en) | 1991-07-31 |
NO301717B1 (no) | 1997-12-01 |
JPH03191789A (ja) | 1991-08-21 |
NO905324L (no) | 1991-06-12 |
EP0437687B1 (de) | 1996-05-15 |
FI101380B1 (fi) | 1998-06-15 |
NO905324D0 (no) | 1990-12-10 |
ES2087109T3 (es) | 1996-07-16 |
ATE137976T1 (de) | 1996-06-15 |
KR0180527B1 (ko) | 1999-04-01 |
JP2950970B2 (ja) | 1999-09-20 |
US5276142A (en) | 1994-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG54177A1 (en) | Process for purification of a 69000 dalton antigenic protein from bordetella pertussis | |
AU533386B2 (en) | Isolation of membrane proteins from neisseria meningitidis and vaccines containing same | |
FI901646A0 (fi) | Kiteinen 2-O- -D-glukopyranosyyli-L-askorbiinihappo ja menetelmä sen valmistamiseksi | |
IT1236039B (it) | Gruppo di riscaldamento controllato per l'estrazione del solvente da fanghi per distillazione,in particolare per macchine lavasecco. | |
HUT56356A (en) | Process for producing thiazolidin-4-ones and 1,3-oxathiolan-5-one derivatives | |
HU9403423D0 (en) | Process for preparing 2,2-difluoro-ketene-silyl-acetals and alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid esters | |
GR870917B (en) | Novel mehthod of preparing toxoid | |
GR3019725T3 (en) | Process | |
ZA872711B (en) | Affinity chromatography material and its use in the separation and purification of protein antigens of the bacteria of the bordetella genus | |
FR2658187B1 (fr) | Nouveaux acides alpha-hydroxyles, procede de preparation et leur utilisation. | |
EP0388181A3 (de) | Hybridisotopentrennungsschema | |
EP0090660A3 (de) | Neisseria Gonorrhöe Vakzin | |
EP0254239A3 (en) | Optically pure 1,3-dioxenones, methods for preparing same and use thereof | |
GR3006773T3 (de) | ||
AU2731088A (en) | Improvements in or relating to antihemophilic factor (AHF) | |
ZA911475B (en) | Process for the separation of yttrium | |
YU117790A (en) | 1,1-dioxopenicillanoyloxymethyl d-6 (methylenamino) fenylacetamido/penicilanat and process for obtaining thereof | |
HU903582D0 (en) | Process for diagnosing virulent bacteria | |
EP0362638A3 (en) | Method of preparing symmetrical and unsymmetrical monoacetals of aromatic 1,2-diketones | |
FR2592884B1 (fr) | Extrait de jacinthe d'eau renfermant des peptides, son procede de preparation et ses utilisations | |
EP0789031A3 (de) | ||
PL285941A1 (en) | Method of obtaining novel alkylsirane block copolymers containing 1,3-dioxane group in its molecule | |
DE3679552D1 (de) | Verfahren zur herstellung von mikroorganismen, insbesondere der gruppe frankia, und herstellung eines bakterieninokulums. | |
YU44386A (en) | Process for preparing new n,n'dialkylguanidino dipeptides | |
MA21523A1 (fr) | Nouveaux procedes d'extraction et de la purification de la diosmine rhamnglucosyl-7 diosmetine,hteroside flavonique elabore par les vegetaux chlorophylliens . |